Onconetix, Inc. Share Price
NASDAQ: ONCO | Micro CapOnconetix, Inc. Stock Performance
Onconetix, Inc. Share Price Today
As of 19 September 2026, Onconetix, Inc.'s share price is $0.66. The stock opened at $0.67, compared to its previous close of $0.66. During today's trading session, Onconetix, Inc.'s share price traded between $0.65 and $0.67, with an average price of $0.66. Over the past 52 weeks, the stock has recorded a high of $6.71 and a low of $0.09. In terms of performance, Onconetix, Inc.'s share price has declined by 56.18% over the last six months and is down 78.09% on a year-on-year basis.
Onconetix, Inc. Share Price Chart
Onconetix, Inc. Quarterly Profit & Loss
All figures in USD
Onconetix, Inc. Annual Profit & Loss
All figures in USD
About Onconetix, Inc.
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Onconetix, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $0.72 | $0.66 | +2.82% |
Aug 2026 | $0.80 | $0.64 | -15.61% |
Jul 2026 | $1.04 | $0.76 | -34.83% |
Jun 2026 | $1.18 | $1.16 | -3.73% |
May 2026 | $0.66 | $1.21 | +75.40% |
Apr 2026 | $1.46 | $0.69 | -54.05% |
Mar 2026 | $0.65 | $1.50 | +126.52% |
Feb 2026 | $1.39 | $0.66 | -55.41% |
Jan 2026 | $1.69 | $1.48 | -7.50% |
Dec 2025 | $2.70 | $1.60 | -41.50% |
Nov 2025 | $3.26 | $2.73 | -27.84% |
Oct 2025 | $3.13 | $3.79 | +26.76% |